Changes of glycolipids dependent on cell density of Ehrlich ascites carcinoma cells. 1984

N V Prokazova, and S L Kocharov, and G I Shaposhnikova, and N D Zvezdina, and L D Bergelson

The glycolipid composition of Ehrlich ascites carcinoma cells was found to depend strongly on the cell density of the suspension. The general trend observed upon dilution of the cell suspension was a reduction of the less complex gangliosides GM3 and GM2 with concomitant increase of the more complex gangliosides, especially GM1. The increase of the content of ganglioside GM1 upon dilution was accompanied by a comparable decrease of the content of its immediate precursor, asialo-GM1, whereas the content of other neutral glycosphingolipids did not change very much. When the cell suspension was diluted with medium conditioned by dense cells the ganglioside profile of the diluted suspension remained similar to that of the dense cell suspension. It is postulated that the medium conditioned with dense cells contains a transferable factor inhibiting sialylation of asialo-GM1.

UI MeSH Term Description Entries
D008297 Male Males
D002286 Carcinoma, Ehrlich Tumor A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms. Ehrlich Ascites Tumor,Ascites Tumor, Ehrlich,Ehrlich Tumor Carcinoma,Tumor, Ehrlich Ascites
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D005732 Gangliosides A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) Ganglioside,Sialoglycosphingolipids
D006017 Glycolipids Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage) Glycolipid
D006028 Glycosphingolipids Lipids containing at least one monosaccharide residue and either a sphingoid or a ceramide (CERAMIDES). They are subdivided into NEUTRAL GLYCOSPHINGOLIPIDS comprising monoglycosyl- and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides; and ACIDIC GLYCOSPHINGOLIPIDS which comprises sialosylglycosylsphingolipids (GANGLIOSIDES); SULFOGLYCOSPHINGOLIPIDS (formerly known as sulfatides), glycuronoglycosphingolipids, and phospho- and phosphonoglycosphingolipids. (From IUPAC's webpage) Asialoganglioside,Asialogangliosides,Glycosphingolipid,Sphingoglycolipid,Sphingoglycolipids
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

N V Prokazova, and S L Kocharov, and G I Shaposhnikova, and N D Zvezdina, and L D Bergelson
March 1981, Cancer letters,
N V Prokazova, and S L Kocharov, and G I Shaposhnikova, and N D Zvezdina, and L D Bergelson
December 1956, Gan,
N V Prokazova, and S L Kocharov, and G I Shaposhnikova, and N D Zvezdina, and L D Bergelson
September 1954, Gan,
N V Prokazova, and S L Kocharov, and G I Shaposhnikova, and N D Zvezdina, and L D Bergelson
March 2013, Bulletin of experimental biology and medicine,
N V Prokazova, and S L Kocharov, and G I Shaposhnikova, and N D Zvezdina, and L D Bergelson
January 1965, Voprosy meditsinskoi khimii,
N V Prokazova, and S L Kocharov, and G I Shaposhnikova, and N D Zvezdina, and L D Bergelson
January 1975, Biofizika,
N V Prokazova, and S L Kocharov, and G I Shaposhnikova, and N D Zvezdina, and L D Bergelson
February 1962, Osaka city medical journal,
N V Prokazova, and S L Kocharov, and G I Shaposhnikova, and N D Zvezdina, and L D Bergelson
July 1973, Doklady Akademii nauk SSSR,
N V Prokazova, and S L Kocharov, and G I Shaposhnikova, and N D Zvezdina, and L D Bergelson
July 1959, Cancer research,
N V Prokazova, and S L Kocharov, and G I Shaposhnikova, and N D Zvezdina, and L D Bergelson
August 1985, The Biochemical journal,
Copied contents to your clipboard!